The clinical symptoms of Parkinson's disease.

Cited by (1,402)

Items 401–500 of 1,402

1. The impact of phyto- and endo-cannabinoids on central nervous system diseases：A review
   Shanshan Zhang, Niu-Niu Zhang, Tiantian Guo, Lee‐Yan Sheen, Chi‐Tang Ho, Naisheng Bai · 2022 · Journal of Traditional and Complementary Medicine
2. Specific Distribution of Digital Gait Biomarkers in Parkinson’s Disease Using Body-Worn Sensors and Machine Learning
   Guoen Cai, Weikun Shi, Ying-Qing Wang, Huidan Weng, Lina Chen, Jiao Yu, Zhonglue Chen, Fabin Lin, Kang Ren, Yuqi Zeng et al. · 2023 · The Journals of Gerontology Series A
3. Temporal Dynamic Alterations of Regional Homogeneity in Parkinson’s Disease: A Resting-State fMRI Study
   Kai Li, Yuan Tian, Haibo Chen · 2023 · Biomolecules
4. β-Caryophyllene decreases neuroinflammation and exerts neuroprotection of dopaminergic neurons in a model of hemiparkinsonism through inhibition of the NLRP3 inflammasome
   Patricia Alejandra Brand-Rubalcava, Aldo Rafael Tejeda-Martínez, Orfil González‐Reynoso, Angelica Y Nápoles-Medina, Verónica Chaparro-Huerta, Mario Eduardo Flores-Soto · 2023 · Parkinsonism & Related Disorders
5. δ-Opioid Receptor Activation Attenuates Hypoxia/MPP+-Induced Downregulation of PINK1: a Novel Mechanism of Neuroprotection Against Parkinsonian Injury
   Yuan Xu, Feng Zhi, Ya Peng, Nan Shao, Dhiaedin Khiati, Gianfranco Balboni, Yilin Yang, Ying Xia · 2018 · Molecular Neurobiology
6. Specialist palliative care for Parkinson’s disease
   David Oliver, Simone Veronese · 2020 · Annals of Palliative Medicine
7. Association of DNMT3b gene variants with sporadic Parkinson's disease in a Chinese Han population
   Xiang 'Anthony' Chen, Yousheng Xiao, Lei Wei, Yijuan Wu, Jianjun Lu, Wenyuan Guo, Shuxuan Huang, Miaomiao Zhou, Mingshu Mo, Zhe Li et al. · 2017 · The Journal of Gene Medicine
8. Assessment of Parkinson's Disease Severity from Videos using Deep Architectures
   Yin, Z. (author) · 2020 · Research Repository (Delft University of Technology)
9. Therapeutic modalities of deferiprone in Parkinson's disease: SKY and EMBARK studies
   David Devos, Olivier Rascol, Wassilios G. Meissner, Alexandra Foubert‐Samier, Simon J.G. Lewis, Christine Tranchant, Mathieu Anheim, David Maltête, Philippe Rémy, Karla Maria Eggert et al. · 2024 · Journal of Parkinson s Disease
10. Effectiveness of Fragment C Domain of Tetanus Toxin and Pramipexole in an Animal Model of Parkinson’s Disease
    Felipe Patricio, Irving Parra, Isabel Martínez, Francisca Pérez‐Severiano, Sergio Montes, José Aguilera, Ilhuicamina Daniel Limón, Yousef Tizabi, Liliana Mendieta · 2019 · Neurotoxicity Research
11. The Role of The Gut Microbiome in Parkinson’s Disease
    Amy Gallop, James S. Weagley, Saif-ur-Rahman Paracha, George Thomas Grossberg · 2021 · Journal of Geriatric Psychiatry and Neurology
12. Longitudinal corpus callosum microstructural decline in early-stage Parkinson’s disease in association with akinetic-rigid symptom severity
    Matthew Amandola, Agniva Sinha, Mark J. Amandola, Hoi‐Chung Leung · 2022 · npj Parkinson s Disease
13. Task-based profiles of language impairment and their relationship to cognitive dysfunction in Parkinson’s disease
    Anja Lowit, Tabea Thies, Julia K. Steffen, Franziska Scheele, Mandy Roheger, Elke Kalbe, Michael T. Barbe · 2022 · PLoS ONE
14. Measuring Brain Activation Patterns from Raw Single-Channel EEG during Exergaming: A Pilot Study
    Gianluca Amprimo, Irene Rechichi, Claudia Ferraris, Gabriella Olmo · 2023 · Electronics
15. Rosinidin inhibits NF-κB/ Nrf2/caspase-3 expression and restores neurotransmitter levels in rotenone-activated Parkinson's disease
    Amira M. Alghamdi, Fahad Ahmed Al-Abbasi, Shareefa Abdullah AlGhamdi, Farhat Fatima, Sami Ibrahim Alzarea, Imran Ahmed Kazmi · 2023 · Saudi Journal of Biological Sciences
16. Novel exposition on reinforcement mechanism of nanoparticles doped gels for early diagnosis of Parkinson's disease
    Fei Wang, Yong Liu, Hongyan Cao, Yanyan Zhao, Yaqing Ge, Xinfeng Song, Chunhui Li, Xueting Yang, Xubao Jiang, Xiangling Gu · 2023 · Composites Science and Technology
17. Harnessing two-dimensional nanomaterials for diagnosis and therapy in neurodegenerative diseases: Advances, challenges and prospects
    Samir Kumar Beura, Abhishek Ramachandra Panigrahi, Pooja Yadav, Irene Palacio, Elena Casero, Carmen Quintana, Jyoti Singh, Sunil Kumar Singh, José Ángel Martín-Gago, Sunil Kumar Singh · 2024 · Ageing Research Reviews
18. Parkinson’s Disease-Associated Mutant LRRK2-Mediated Inhibition of miRNA Activity is Antagonized by TRIM32
    Laura González-Cano, Ingeborg Menzl, Johan Tisserand · 2017 · Molecular Neurobiology
19. Drug polarity effect over the controlled release in casein and chondroitin sulfate-based hydrogels
    Andressa Renatta Simão, Vanessa H. Fragal, Michelly Cristina Galdioli Pellá · 2020 · International Journal of Biological Macromolecules
20. Perceptual Characterization of Voice Quality in Nonadvanced Stages of Parkinson's Disease
    Zoë Thijs, Christopher R. Watts · 2020 · Journal of Voice
21. Immune-associated biomarkers for early diagnosis of Parkinson’s disease based on hematological lncRNA–mRNA co-expression
    Kecheng Lei, Liwen Zhang, Yijing He, Hui Sun, Weifang Tong, Yichun Xu, Lingjing Jin · 2020 · Bioscience Reports
22. NF‑κB is negatively associated with Nurr1 to reduce the inflammatory response in Parkinson's disease
    Hua Gao, Dan Wang, Sen Jiang · 2021 · Molecular Medicine Reports
23. Effects of Treadmill Exercise on Neural Mitochondrial Functions in Parkinson’s Disease: A Systematic Review of Animal Studies
    Nguyen Thanh Nhu, Yu‐Jung Cheng, Shin‐Da Lee · 2021 · Biomedicines
24. Mediating role of caregiver burden among family caregivers of patients with Parkinson’s disease in Mexico
    Stephen K. Trapp, Justin J. MacKenzie, Susana González-Arredondo, Yaneth Rodríguez‐Agudelo, Juan Carlos Arango‐Lasprilla · 2018 · The International Journal of Psychiatry in Medicine
25. Comprehensive multimodal approach for Parkinson’s disease classification using artificial intelligence: insights and model explainability
    Hossam Magdy Balaha, Asmaa El-Sayed Hassan, Rawan Ayman Ahmed · 2025 · Soft Computing
26. Motor and nonmotor symptoms in patients treated with 24-hour daily levodopa-carbidopa intestinal gel infusion: Analysis of the COmedication Study assessing Mono- and cOmbination therapy with levodopa-carbidopa inteStinal gel (COSMOS)
    Norbert Kovács, József Attila Szász, Lydia Vela, Per Svenningsson, Samira Femia, Juan Carlos Parra, Olga Sánchez‐Soliño, Lars Bergmann, Tanya Gurevich, Alfonso A. Fasano · 2022 · Parkinsonism & Related Disorders
27. Parkinson’s Disease, It Takes Guts: The Correlation between Intestinal Microbiome and Cytokine Network with Neurodegeneration
    Georgia Xiromerisiou, Chrysoula Marogianni, Anastasia Androutsopoulou, Panagiotis Ntavaroukas, Dimitrios S. Mysiris, Stamatia Papoutsopoulou · 2023 · Biology
28. AMPK signaling pathway as a potential therapeutic target for Parkinson's disease
    Seyed Zanyar Athari, Fereshteh Farajdokht, ‬Rana Keyhanmanesh, Gisou Mohaddes · 2023 · Advanced Pharmaceutical Bulletin
29. Modulating Stress Proteins in Response to Therapeutic Interventions for Parkinson’s Disease
    Serena Silvestro, Ivana Raffaele, Emanuela Mazzon · 2023 · International Journal of Molecular Sciences
30. Convolutional neural network based detection of early stage Parkinson’s disease using the six minute walk test
    Hyejin Choi, Changhong Youm, Hwayoung Park · 2024 · Scientific Reports
31. Why Palliative Care Applies to Parkinson's Disease
    Raquel Bouça‐Machado, Herma H. Lennaerts, Bastiaan R. Bloem, Joaquim José Ferreira · 2018 · Movement Disorders
32. Cardinal Motor Features of Parkinson’s Disease Coexist with Peak-Dose Choreic-Type Drug-Induced Dyskinesia
    Étienne Goubault, Hung Nguyen, Sarah Bogard, Pierre J. Blanchet, Erwan Bézard, Claude Vincent, Mélanie Langlois, Christian Duval · 2018 · Journal of Parkinson s Disease
33. Non-motor symptoms in newly diagnosed Parkinson’s disease patients
    Osama Abd Allah Ragab, Yasser A. A. El-Heneedy, Wafik Said Bahnasy · 2019 · The Egyptian Journal of Neurology Psychiatry and Neurosurgery
34. Treatment Patterns in Patients with Incident Parkinson’s Disease in the United States
    Richard Houghton, Frank Boess, Lynne M. Verselis · 2019 · Journal of Parkinson s Disease
35. Hypocretin (Orexin) Replacement Therapies
    Erica M. Seigneur, Luı́s de Lecea · 2020 · Medicine in Drug Discovery
36. Further Characterization of Intrastriatal Lipopolysaccharide Model of Parkinson’s Disease in C57BL/6 Mice
    Isaac Bul Deng, Frances Corrigan, Sanjay Garg, Xin‐Fu Zhou, Larisa Bobrovskaya · 2021 · International Journal of Molecular Sciences
37. LINC00943 acts as miR-338-3p sponge to promote MPP+-induced SK-N-SH cell injury by directly targeting SP1 in Parkinson’s disease
    Xiaoming Sun, Chunyuan Zhang, Tao Hong, Shuyong Yao, Xueliang Wu · 2022 · Brain Research
38. Impaired dynamic cerebral autoregulation: A potential mechanism of orthostatic hypotension and dementia in Parkinson’s disease
    Hongxiu Chen, Erhe Xu, Fubo Zhou, Qiuping Li, Jingrong Zeng, Shanshan Mei, Yingqi Xing · 2022 · Frontiers in Aging Neuroscience
39. Sulfide:quinone oxidoreductase ameliorates neurodegeneration in a murine model of Parkinson's disease
    Fumiaki Nagashima, Yusuke Miyazaki, Eiki Kanemaru, Mariko Ezaka, Hiroaki Hara, Kei Sugiura, Sophie L. Boerboom, Katrina F. Ostrom, Wanlin Jiang, Donald B. Bloch et al. · 2022 · Redox Biology
40. Systemic Rotenone Administration Causes Extra-Nigral Alterations in C57BL/6 Mice
    Sarah Thomas Broome, Alessandro Castorina · 2022 · Biomedicines
41. Abscisic acid, an evolutionary conserved hormone: Biosynthesis, therapeutic and diagnostic applications in mammals
    Amir Gharib, Carlee Marquez, María Meseguer-Beltrán, Sandra Sánchez‐Sarasúa, Ana María Sánchez‐Pérez · 2024 · Biochemical Pharmacology
42. Spatial disorientation and executive dysfunction in elderly nondemented patients with Parkinson’s disease
    Davide Maria Cammisuli, Simon F. Crowe · 2018 · Neuropsychiatric Disease and Treatment
43. The effects simultaneous inhibition of dipeptidyl peptidase-4 and P2X7 purinoceptors in an in vivo Parkinson’s disease model
    Nida Jamali-Raeufy, Zahra Mojarrab, Tourandokht Baluchnejadmojarad, Mehrdad Roghani, Javad Fahanik Babaei, Mina Goudarzi · 2020 · Metabolic Brain Disease
44. Acceptability and practicability of self-management for patients with Parkinson’s disease based on smartphone applications in China
    Jie Hu, Dezhi Yuan, Qiuye Zhao, X. F. Wang, X. T. Zhang, Q. H. Jiang, Hanyu Luo, Jinfang Li, J. H. Ran, J. F. Li · 2020 · BMC Medical Informatics and Decision Making
45. Methodological Considerations for Neuroimaging in Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson’s Disease Patients
    Bethany Rose Isaacs, Max Cornelis Keuken, Anneke Alkemade, Yasin Temel, Pierre‐Louis Bazin, Birte U. Forstmann · 2020 · Journal of Clinical Medicine
46. The Drosophila Model: Exploring Novel Therapeutic Compounds against Neurodegenerative Diseases
    Sun Joo Cha, Hyeon‐Ah Do, Hyun‐Jun Choi, Mihye Lee, Kiyoung Kim · 2019 · Antioxidants
47. Elevated circulating magnesium levels in patients with Parkinson’s disease: a meta-analysis
    Xin Jin, Mingyan Liu, Dongfang Zhang, Hua Gao, Minjie Wei · 2018 · Neuropsychiatric Disease and Treatment
48. The endothelial surface layer-glycocalyx - Universal nano-infrastructure is fundamental to physiology, cell traffic and a complementary neural network
    Barry William Ninham, Nikolai F. Bunkin, Matthew Battye · 2025 · Advances in Colloid and Interface Science
49. Neuroimaging-based data-driven subtypes of spatiotemporal atrophy due to Parkinson’s disease
    Zeena Shawa, Cameron Shand, Beatrice Taylor, Henk W. Berendse, Chris Vriend, Tim D. van Balkom, Odile A. van den Heuvel, Ysbrand D. van der Werf, Jiun‐Jie Wang, Chih‐Chien Tsai et al. · 2025 · Brain Communications
50. The relationship between attention and static balance disturbance in patients with Parkinson’s disease
    Amir Dana, Amir Shams, ناهید علافان, Alireza Bahrami · 2021 · Neurological Sciences
51. Time-Course of Alterations in the Endocannabinoid System after Viral-Mediated Overexpression of α-Synuclein in the Rat Brain
    Rachel L. Kelly, Alexis‐Pierre Bemelmans, Charlène Joséphine, Emmanuel Brouillet, Declan Patrick McKernan, Eilís Dowd · 2022 · Molecules
52. MiR‐9‐5p Inhibits the MMP+‐Induced Neuron Apoptosis through Regulating SCRIB/β‐Catenin Signaling in Parkinson’s Disease
    Zhenyong Xiao, Zhenxing Yan, Xiang Sun, Zhiyuan Zhu, Baoyan Wang, Mengqi Gao, Fengfei Lu, Jian Liu, Zhitao Zong, Hongbo Zhang et al. · 2022 · Oxidative Medicine and Cellular Longevity
53. Use of common spatial patterns for early detection of Parkinson’s disease
    A. Smrdel · 2022 · Scientific Reports
54. Machine learning identifies phenotypic profile alterations of human dopaminergic neurons exposed to bisphenols and perfluoroalkyls
    Andrea Di Credico, Amélie Weiss, Massimo Corsini, Giulia Gaggi, Barbara Ghinassi, Johannes H. Wilbertz, Angela Di Baldassarre · 2023 · Scientific Reports
55. Study on the Correlation between Blood Urea Nitrogen, Creatinine Level, Proteinuria and Parkinson's Disease
    Guang Yang, Ling Zhi Wang, Rong Zhang · 2023 · Neurology India
56. Prediction of Freezing of Gait in Parkinson's disease based on multi-channel time-series neural network
    Boyan Wang, Xuegang Hu, Rongjun Ge, Chenchu Xu, Jinglin Zhang, Zhi-Fan Gao, Shu Zhao, Kemal Polat · 2024 · Artif. Intell. Medicine
57. Classification of brain disease in magnetic resonance images using two-stage local feature fusion
    Tao Li, Wu Li, Yehui Yang, Wensheng Zhang · 2017 · PLoS ONE
58. Diagnosing Parkinson’s Disease Using Multimodal Physiological Signals
    Guoxin Guo, Shujie Wang, Wang Shuaibin, Zhiyu Zhou, Guangying Pei, Tianyi Yan · 2021 · Communications in computer and information science
59. Protective effect of Actinidia arguta in MPTP-induced Parkinson’s disease model mice
    Yuki Kitamura, Mayuko Sakanashi, Azuki Ozawa, Yuri Saeki, Ayano Nakamura, Yuiho Hara, Ken‐ichi Saeki, Sakae Arimoto‐Kobayashi · 2021 · Biochemical and Biophysical Research Communications
60. Multidisciplinary intensive outpatient rehabilitation program for patients with moderate-to-advanced Parkinson’s disease
    Noa Cohen, Yael Manor, Yitzhak Green et al. · 2021 · Neurorehabilitation
61. Discovery of 3,4-dichloro-N-(1H-indol-5-yl)benzamide: A highly potent, selective, and competitive hMAO-B inhibitor with high BBB permeability profile and neuroprotective action
    Ahmed Elkamhawy, Hyeon Jeong Kim, Mohamed H. Elsherbeny et al. · 2021 · Bioorganic Chemistry
62. Early Repetitive Transcranial Magnetic Stimulation Exerts Neuroprotective Effects and Improves Motor Functions in Hemiparkinsonian Rats
    Tsung-Hsun Hsieh, Xiaokuo He, Hui-Hua Liu, Jia‐Jin Jason Chen, Chih‐Wei Peng, Hao‐Li Liu, Alexander Rotenberg, Ko‐Ting Chen, Ming‐Yuan Chang, Yung Hsiao Chiang et al. · 2021 · Neural Plasticity
63. Refinement of the dopaminergic system of anuran amphibians based on connectivity with habenula, basal ganglia, limbic system, pallium, and spinal cord
    Lars Freudenmacher, Maria Schauer, Wolfgang Walkowiak, Arndt von Twickel · 2019 · The Journal of Comparative Neurology
64. The role of iron in Parkinson's disease monkeys assessed by susceptibility weighted imaging and inductively coupled plasma mass spectrometry
    Shaojun Li, Yande Ren, Jin Li, Bin Cao, Chi Ma, Shanshan Qin, Xiangrong Li · 2019 · Life Sciences
65. Work Loss and Direct and Indirect Costs Associated with Parkinson’s Disease
    Michelle Jerry, Steve Arcona, Donna McMorrow · 2023 · ClinicoEconomics and Outcomes Research
66. Toward Personalized Medicine Approaches for Parkinson Disease Using Digital Technologies
    Amit Khanna, Graham B. Jones · 2023 · JMIR Formative Research
67. Agreement between Optoelectronic System and Wearable Sensors for the Evaluation of Gait Spatiotemporal Parameters in Progressive Supranuclear Palsy
    Carlo Ricciardi, Noemi Pisani, Leandro Donisi, Filomena Abate, Marianna Amboni, Paolo Barone, Marina Picillo, Mario Cesarelli, Francesco Amato · 2023 · Sensors
68. Sodium butyrate activates the KATP channels to regulate the mechanism of Parkinson's disease microglia model inflammation
    Ye Xu, Laofu Wen, Yunyi Tang, Zhenqiang Zhao, Miaojing Xu, Tan Wang, Zhibin Chen · 2024 · Immunity Inflammation and Disease
69. The Contribution of Type 2 Diabetes to Parkinson’s Disease Aetiology
    Samo Ribarič · 2024 · International Journal of Molecular Sciences
70. Mitochondria-Associated MicroRNAs and Parkinson’s Disease
    Gayatri Reddy Aaluri, Yashmit Choudhary, Subodh Kumar · 2024 · Neuroscience Insights
71. A causal counterfactual graph neural network for arising-from-chair abnormality detection in parkinsonians
    Xinlu Tang, Rui Guo, Chencheng Zhang, Xiaohua Qian · 2024 · Medical Image Analysis
72. Kinematic and Kinetic Gait Features Associated With Mild Cognitive Impairment in Parkinson’s Disease
    Michela Russo, Marianna Amboni, Antonio Volzone, Sofia Cuoco, Richard M. Camicioli, Federico Di Filippo, Paolo Barone, Maria Romano, Francesco Amato, Carlo Ricciardi · 2024 · IEEE Transactions on Neural Systems and Rehabilitation Engineering
73. A National Snapshot Detailing the Impact of Parkinson's Disease on the Cost and Outcome Profiles of Fusion Procedures for Cervical Myelopathy
    Michael L. Martini, Brian C. Deutsch, Sean N. Neifert · 2019 · Neurosurgery
74. Effect of Nanomicelle Curcumin on Quality of Life and Sleep in Patients With Parkinson’s Disease: A Double-Blind, Randomized, and PlaceboControlled Trial
    Mehdi Maghbooli, Bahareh Safarnejad, Hossein Mostafavi, Saeideh Mazloomzadeh, Abdoreza Ghoreishi · 2019 · International Clinical Neuroscience Journal
75. Disparities in depression among Chinese older adults with neurodegenerative diseases
    Zhichao Hao, Nicole Ruggiano, Qingyi Li, Yuqi Guo, Xiaofu Pan · 2021 · Aging & Mental Health
76. Assessment of myocardial sympathetic innervation with 18F-FDOPA-PET/CT in patients with autonomic dysfunction: feasibility study in IPD patients
    Harish Goyal, Anshul Sharma, Chetan D. Patel, Kishore Kumar Deepak, Madhavi Tripathi, Priyanka Gupta, Rajeev Kumar, Chandra Shekhar Bal, Vinay Goyal · 2021 · Journal of Nuclear Cardiology
77. The Correlation Between Parkinson’s Disease and Rapid Eye Movement Sleep Behavior Disorder: A Systematic Review
    Niki Shrestha, Rose Anne M Abe, Anum Masroor, Arseni Khorochkov, Jose Prieto, Karan Bahadur Singh, Maduka C Nnadozie, Muhammad Abdal, Lubna Mohammed · 2021 · Cureus
78. Gut microbiota and inflammation in Parkinson’s disease: Pathogenetic and therapeutic insights
    Tong Guo, Li Chen · 2022 · European Journal of Inflammation
79. A comprehensive bioinformatic analysis revealed novel MicroRNA biomarkers of Parkinson's disease
    Alireza Rahimpour, Roozbeh Heidarzadehpilehrood, Sepideh Abdollahi, Haidar Ranjbari, Zinat Shams, Seyed Abbas Ghasemi, Shima Najmaei, Maryam Pirhoushiaran · 2022 · Cell Biology International
80. Motor imagery vividness and symptom severity in Parkinson's disease
    Megan Rose Readman, Trevor J. Crawford, Sally A. Linkenauger, Judith Bek, Ellen Poliakoff · 2022 · Journal of Neuropsychology
81. Gait Characteristics Analyzed with Smartphone IMU Sensors in Subjects with Parkinsonism under the Conditions of “Dry” Immersion
    A. Yu. Meigal, Liudmila I. Gerasimova-Meigal, Sergey Reginya · 2022 · Sensors
82. The Impact of the COVID-19 Pandemic on Informal Caregivers of People With Parkinson’s Disease Residing in the UK: A Qualitative Study
    Daniel Rippon, Annette Hand, Lorelle Louise Dismore, Roberta Caiazza · 2022 · Journal of Geriatric Psychiatry and Neurology
83. Exercise-Boosted Mitochondrial Remodeling in Parkinson’s Disease
    Juan Carlos Magaña, Cláudia M. Deus, Maria Giné‐Garriga, Joel Montané, Susana P. Pereira · 2022 · Biomedicines
84. Unveiling new secrets in Parkinson’s disease: The glycatome
    Ana Chegão, Hugo Vicente Miranda · 2023 · Behavioural Brain Research
85. NLRP3 mediates the neuroprotective effects of SVHRSP derived from scorpion venom in rotenone-induced experimental Parkinson’s disease model
    Yu Zhang, Sheng Li, Liyan Hou, Mingyang Wu, Jianing Liu, Ruonan Wang, Qingshan Wang, Jie Zhao · 2023 · Journal of Ethnopharmacology
86. What Dietary Vitamins and Minerals Might Be Protective against Parkinson’s Disease?
    Mohammad Alizadeh, Sorayya Kheirouri, Majid Keramati · 2023 · Brain Sciences
87. A Pilot Study to Determine the Consistency of Simultaneous Sleep Actigraphy Measurements Comparing All Four Limbs of Patients with Parkinson Disease
    Vineet Prasad, Cary A. Brown · 2017 · Geriatrics
88. Pharmacoacupuncture for Idiopathic Parkinson’s Disease: A Systematic Review of Randomized Controlled Trials
    Ki‐Ho Cho, Tae‐Hun Kim, Woo‐Sang Jung, Sang‐Kwan Moon, Chang‐Nam Ko, Seung‐Yeon Cho, Chan‐Yong Jeon, Tae‐Young Choi, Myeong Soo Lee, Sang-Ho Lee et al. · 2018 · Evidence-based Complementary and Alternative Medicine
89. Case of Early-Onset Parkinson’s Disease in a Heterozygous Mutation Carrier of the ATP7B Gene
    Ekaterina Yu. Ilyechova, Irina V. Miliukhina, Marina N. Karpenko, Iurii A. Orlov, Ludmila V. Puchkova, Sergey A. Samsonov · 2019 · Journal of Personalized Medicine
90. Biological Sex and Sex Hormone Impacts on Deficits in Episodic-Like Memory in a Rat Model of Early, Pre-motor Stages of Parkinson's Disease
    Meagan R. Conner, Doyeon Jang, Brenda J. Anderson, Mary F. Kritzer · 2020 · Frontiers in Neurology
91. Association of SNCA Parkinson's Disease Risk Polymorphisms With Disease Progression in Newly Diagnosed Patients
    Aleksandra A. Szwedo, Camilla Christina Pedersen, Anastasia Ushakova, Lars Forsgren, Ole‐Bjørn Tysnes, Carl E Counsell, Guido Werner Alves, Johannes Lange, Angus D. Macleod, Jodi Maple‐Grødem · 2021 · Frontiers in Neurology
92. Irritable bowel syndrome and subsequent risk of Parkinson’s disease: a nationwide population-based matched-cohort study
    Seo Yeon Yoon, Jaeyong Shin, Seok‐Jae Heo, Jee Suk Chang, Mun Kyung Sunwoo, Yong Wook Kim · 2021 · Journal of Neurology
93. Multimodal I-vectors to Detect and Evaluate Parkinson's Disease
    Garcia, Nicanor, Vásquez Correa, Juan Camilo, Orozco-Arroyave, Juan Rafael, Nöth, Elmar · 2018 · Interspeech 2018
94. The somato-cognitive action network links diverse neuromodulatory targets for Parkinson’s disease
    Jianxun Ren, Wei Zhang, Louisa Dahmani, Qingyu Hu, Changqing Jiang, Yan Bai, Gong‐Jun Ji, Ying Zhou, Ping Zhang, Weiwei Wang et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
95. Ginkgolide B regulates apoptosis, oxidative stress, and mitochondrial dysfunction in MPP+-induced SK-N-SH cells by targeting HDAC4/JNK pathway
    Ding Xu, Dongming Tan, Zhao Wang · 2025 · Naunyn-Schmiedeberg s Archives of Pharmacology
96. Machine Learning-Based Assessment of Parkinson’s Disease Symptoms Using Wearable and Smartphone Sensors
    Tomasz Gutowski, Olga Stodulska, Aleksandra Ćwiklińska, Katarzyna Gutowska, Kamila Kopeć, Marta Maria Betka, Ryszard Antkiewicz, Dariusz Koziorowski, Stanisław Szlufik · 2025 · Sensors
97. Artificial intelligence and multi-omics nominate TAZ as an insomnia-related diagnostic and druggable target for Parkinson’s disease patients
    Wenjing Ma · 2026 · Frontiers in Aging Neuroscience
98. Socially Assistive Robots for Parkinson's Disease: Needs, Attitudes and Specific Applications as Identified by Healthcare Professionals
    Inbal Bar-On, Gili Mayo, Shelly Levy‐Tzedek · 2022 · ACM Transactions on Human-Robot Interaction
99. Clinical and Non-Clinical Cardiovascular Disease Associated Pathologies in Parkinson’s Disease
    Bonn Lee, Charlotte E. Edling, Shiraz Ahmad, Fiona E. N. LeBeau, Gary Tse, Kamalan Jeevaratnam · 2023 · International Journal of Molecular Sciences
100. Noninvasive Neuromodulation in Parkinson’s Disease: Insights from Animal Models
     Katherine Muksuris, David M. Scarisbrick, James Joseph Mahoney, Mariya V. Cherkasova · 2023 · Journal of Clinical Medicine